| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, REVB returned -90.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -65.9% |
| 1 year | -90.7% |
| 5 years | -100.0% |
| All-time high | $2,066,400.00 (Feb 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in REVB would be worth today ›No. Revelation Biosciences, Inc. has not paid a dividend in the past 12 months.
Revelation Biosciences, Inc. stock trades on NASDAQ under the ticker symbol REVB.
Revelation Biosciences, Inc. is part of the Healthcare sector.
Revelation Biosciences, Inc. has a market cap of 4.34M USD, based on the latest quote.
Revelation Biosciences, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
